Yidu Tech Convenes 28 Aug 2026 AGM to Endorse FY26 Results, Final Dividend, Board Changes and 30% Share Mandates

Yidu Tech Inc. (Stock code: 02158), a Cayman-incorporated healthcare technology group, has issued a notice to shareholders convening its Annual General Meeting (AGM) for 11:00 a.m. on Friday, 28 August 2026, at the company’s Beijing headquarters (1/F, Building 22, Lincui Xili Phase 3, Chaoyang District).

Key resolutions to be tabled include:

1. FY26 Results & Dividend • Shareholders will be asked to receive and adopt the audited consolidated financial statements for the year ended 31 March 2026 together with the Directors’ and auditor’s reports. • A final dividend for FY26 is proposed; shareholders on the register as at 7 September 2026 will be entitled to receive the payout. The share register will be closed from 3 September to 7 September 2026 (both days inclusive) for dividend entitlement.

2. Board Composition & Remuneration • Independent non-executive directors Dr Ma Wei-Ying and Ms Pan Rongrong are nominated for re-election. • The Board will be authorised to set directors’ remuneration.

3. Auditor Re-appointment • PricewaterhouseCoopers is nominated to continue as the Company’s external auditor until the next AGM, with remuneration to be determined by the Board.

4. Issuance & Repurchase Mandates • General mandate to allot, issue or deal with additional shares and transfer treasury shares up to 20% of issued share capital (excluding treasury shares) during the mandate period. • Authority to repurchase up to 10% of issued shares (excluding treasury shares) on the Hong Kong Stock Exchange or other recognised bourses. • Conditional extension allowing the issuance mandate to be increased by the number of shares repurchased, effectively enabling the Board to manage up to 30% of issued share capital.

Key Timetable • Closure for AGM voting eligibility: 25–28 August 2026 (inclusive); record date: 28 August 2026. • Closure for dividend entitlement: 3–7 September 2026 (inclusive); record date: 7 September 2026. • Proxy forms must be lodged by 11:00 a.m. on 26 August 2026.

The Board currently comprises three executive directors (Ms Gong Yingying, Mr Xu Jiming, Ms Feng Xiaoying), one non-executive director (Mr Zeng Ming) and three independent non-executive directors (Dr Ma Wei-Ying, Ms Pan Rongrong, Prof Zhang Linqi).